1,067
Views
10
CrossRef citations to date
0
Altmetric
Research Papers

Harnessing benefit from targeting tumor associated carbohydrate antigens

, , , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ashraf Abdullah Saad. (2022) Targeting cancer-associated glycans as a therapeutic strategy in leukemia. All Life 15:1, pages 378-433.
Read now

Articles from other publishers (9)

René Roy & Leila Mousavifar. (2023) Carrier diversity and chemical ligations in the toolbox for designing tumor-associated carbohydrate antigens (TACAs) as synthetic vaccine candidates. Chemical Society Reviews 52:10, pages 3353-3396.
Crossref
Ying Zhou, Yintao Zhang, Xichen Lian, Fengcheng Li, Chaoxin Wang, Feng Zhu, Yunqing Qiu & Yuzong Chen. (2022) Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents. Nucleic Acids Research 50:D1, pages D1398-D1407.
Crossref
Charles L. Hitchcock, Stephen P. Povoski, Cathy M. Mojzisik & Edward W. MartinJrJr. (2021) Survival Advantage Following TAG-72 Antigen-Directed Cancer Surgery in Patients With Colorectal Carcinoma: Proposed Mechanisms of Action. Frontiers in Oncology 11.
Crossref
Magdalena Thurin. (2021) Tumor-Associated Glycans as Targets for Immunotherapy: The Wistar Institute Experience/Legacy. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 40:3, pages 89-100.
Crossref
Sabrina M. Piazza, Michael R. Reynolds, Jonathan Chiaramonte, Peihan Xu, Fabiola A. Chapa-Villarreal & John F. Trant. (2021) Efficient and reproducible synthesis of an Fmoc-protected Tn antigen. New Journal of Chemistry.
Crossref
Allison M. Dyevoich, Nataya S. Disher, Marcela A. Haro & Karen M. Haas. (2020) A TLR4–TRIF-dependent signaling pathway is required for protective natural tumor-reactive IgM production by B1 cells. Cancer Immunology, Immunotherapy 69:10, pages 2113-2124.
Crossref
Yongjiang Li, Ciceron Ayala-Orozco, Pradipta Ranjan Rauta & Sunil Krishnan. (2019) The application of nanotechnology in enhancing immunotherapy for cancer treatment: current effects and perspective. Nanoscale 11:37, pages 17157-17178.
Crossref
Marcela A. Haro, Allison M. Dyevoich, James P. Phipps & Karen M. Haas. (2019) Activation of B-1 Cells Promotes Tumor Cell Killing in the Peritoneal Cavity. Cancer Research 79:1, pages 159-170.
Crossref
Laura F. Hutchins, Issam Makhoul, Peter D. Emanuel, Angela Pennisi, Eric R. Siegel, Fariba Jousheghany, Xueyan Guo, Anastas D. Pashov, Behjatolah Monzavi-Karbassi & Thomas Kieber-Emmons. (2017) Targeting tumor-associated carbohydrate antigens: a phase I study of a carbohydrate mimetic-peptide vaccine in stage IV breast cancer subjects. Oncotarget 8:58, pages 99161-99178.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.